A Real-World Analysis of the Clinical Journey, Diagnosis, and Monitoring Patterns of Patients With Alzheimer Disease by Stage in the United States
Prediction of infusion capacity to deliver Alzheimer’s disease treatments in the United States relative to expected demand
A preliminary economic evaluation of a potential program for the primary prevention of Alzheimer’s disease
Estimation of the value-based price of a blood test for Alzheimer’s disease pathology in primary and specialty care in the U.S
Demographic and clinical characteristics of initial patients receiving amyloid-targeting treatments in the United States after regulatory approval